Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why

It is well known that chemotherapy can cure only some cancers in advanced stage, mostly those with an intact p53 pathway. Hematological cancers such as lymphoma and certain forms of leukemia are paradigmatic e...

Source: Journal of Hematology and Oncology - May 31, 2018 Category: Hematology Authors: Enrico Derenzini, Alessandra Rossi and Davide Trer é Tags: Review Source Type: research